Although a number of other post-translational modifications beyond pS129 have been described for α-synuclein, some of which appear to regulate α-synuclein aggregation in vitro, the extent to which these occur in individuals with DLB and thus play a role in disease remains unclear [72]. Here, SNCA is linked to Lewy body dementia.